Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study-Reference-Cited by-同舟云学术

Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study

Published:2021-12-17 Issue: Volume: Page:
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Sarkar Gouranga,Gaikwad Vijay B.,Sharma Aradhana,Halder Swapan K.,Kumar Darivemula A.,Anand Jitendra,Agrawal Sumit,Kumbhar Avinash,Kinholkar Bhushan,Mathur Rishabh,Doshi Maulik,Bachani Deepak,Mehta Suyog

Funder

Sun Health Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-01971-9.pdf

Reference53 articles.

1. Lawes CM, Vander Hoorn S, Rodgers A, International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.

2. Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15:134–6.

3. Sivasubramanian R, Geevar Z, Kartik G, et al. Prevalence of hypertension among Indian adults: results from the great India blood pressure survey. Indian Heart J. 2019;71:309–13.